New

Radiopharmaceuticals Market

2021

Radiopharmaceuticals Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Diagnostic Nuclear Medicine and Therapeutic Nuclear Medicine), Product Type (Technetium-99m, Thallium-201, Gallium-67, Iodine-131, Copper-64, and Other), Application (Oncology, Cardiology, Neurology, and Others), and End User (Hospitals, Imaging Centers, Academic and Research Centers, and Others)

Publication Month: Aug 2021 | Report Code: TIPRE00003751 | No. of Pages: 220 | Category: Pharmaceuticals | Status: Published

Market Insights

Radiopharmaceuticals Market to Grow at a CAGR of 9.0% to reach US$ 13,818.17 Million from 2020 to 2028

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!

The radiopharmaceuticals market is projected to reach US$ 13,818.17 million by 2028 from US$ 7,550.74 million in 2021; it is expected to grow at a CAGR of 9.0% from 2021 to 2028.

The growth of the market is attributed to the rising prevalence of chronic diseases, suitability of alpha radioimmunotherapy in targeted cancer treatment, and advancements in nuclear imaging techniques. However, the short shelf-life of radiopharmaceuticals and availability of substitutes restrain the Radiopharmaceuticals market growth. A radiopharmaceutical is a drug that can be used either for diagnostic or therapeutic purposes. Radiopharmaceuticals are radioisotopes that are bound to biological molecules that target specific tissues, organs, or cells within the human body. Radioisotopes emitting gamma rays are useful for diagnostic imaging where the radiation escapes the body. These rays are detected by a specific device, which is usually single-photon emission computed tomography (SPECT)/positron emission tomography (PET) cameras.

The COVID-19 pandemic has profoundly changed hospital activities, including nuclear medicine (NM) practices across Europe. A literature search on PubMed was performed covering COVID-19 studies published up until January 2021. As per the findings, the pandemic strongly challenged NM departments, and a reduction in the workforce has been experienced in every center in Europe. To limit COVID-19 transmission, NM departments introduced restriction measures, such as the rescheduling of non-high-priority procedures. Also, a few of the departments experienced a delay in radiopharmaceuticals supply or technical assistance due to the pandemic. As a result, the crisis resulted in a significant reduction of diagnostic and therapeutic NM procedures and a reduced level of care for patients affected by diseases, such as cancer or acute cardiovascular disease.


Lucrative Regions for Radiopharmaceuticals Market

Lucrative Regions for Radiopharmaceuticals Market

Get more information on this report :



Market Insights

Rising Prevalence of Chronic Diseases Fuels Radiopharmaceuticals Market Growth

The prevalence of chronic diseases such as cardiovascular diseases (CVDs), cancer, chronic lung diseases, stroke, Alzheimer’s disease, chronic kidney disease, and several neurological disorders is increasing rapidly across the world. These diseases are among the leading causes of death. As per the World Health Organization (WHO), cancer accounted for ~10 million deaths in 2020 globally. Furthermore, as per the estimations of the American Cancer Society, ~1,806,590 new cases of cancer were diagnosed in the US in 2020. As per the European Heart Network, CVDs cause 3.9 million deaths in Europe and more than 1.8 million deaths in the European Union (EU) every year. They account for 45.0% of total mortalities in Europe and 37.0% of the total death count in the EU. As per the American College of Cardiology, CVDs cause ~800,000 death cases in the US every year. Coronary heart disease (CHD) contributes to a majority of CVD mortalities, followed by stroke and heart failure; ~90 million Americans are diagnosed with CVDs per year. In addition, CVDs contribute to ~31% of total death globally, and the cost burden of CVDs on healthcare systems is expected to be ~US$ 1,044 billion by 2030.

According to Emory Healthcare, in 2018, ~5 million people suffer from congestive heart failure (CHF) in the US. Further, according to the WHO, ~1.71 billion people in the world are suffering from musculoskeletal conditions. An effective examination is a must for the treatment of chronic diseases, and nuclear substances are used for diagnosis and examination purposes; they are used in diagnostic tests such as positron emission tomography (PET) and single-photon emission computerized tomography (SPECT). Thus, with a surge in the incidence of chronic diseases, the need for radiopharmaceuticals is also increasing, thereby driving the market growth.


Type-Based Insights

Based on type, the radiopharmaceuticals market is bifurcated into diagnostic nuclear medicine and therapeutic nuclear medicine. The diagnostic nuclear medicine segment is holding a larger share of the market and is expected to register a higher CAGR during 2021–2028. The radioisotope used widely in diagnostic nuclear medicine is technetium-99m. The radioisotope attaches to several specific molecules, allowing the diagnosis of various diseases, such as the certain types of cancers. For instance, technetium-99m-MDP (methylene diphosphonate) is widely used to detect bone metastasis associated with cancer.

Radiopharmaceuticals Market, by Type – 2021 and 2028

Radiopharmaceuticals Market, by Type – 2021 and 2028

Get more information on this report :



Product Type-Based Insights

Based on product type, the radiopharmaceuticals market is segmented into Technetium-99m, Thallium-201, Gallium-67, Iodine-131, Copper-64, and other. The Technetium-99m segment is holding the largest share of the market, whereas the gallium-67 segment is expected to register the highest CAGR during 2021–2028. Gallium-67 is used for the imaging and localization of inflammatory lesions (infections). Gallium-67 is an injectable radiopharmaceutical that is used with single photon emission computed tomography (SPECT) to detect the presence of acute inflammatory lesions and various malignancies, such as Hodgkin’s disease, lymphomas, and bronchogenic carcinomas.

Application-Based Insights

Based on application, the radiopharmaceuticals market is segmented into oncology, cardiology, neurology, and others. The oncology segment is holding the largest share of the market. The market growth for this segment can be attributed to the increasing incidence of cancer worldwide. Cancer is one of the significant health problems with a high mortality rate. It is a threat to global health. As per the WHO, in 2018, an estimated 18 million new cancer cases were diagnosed worldwide, and 9.6 million people died from cancer. However, the market for the cardiology segment is expected to grow at the fastest rate in the coming years.

End User-Based Insights

Based on end user, the radiopharmaceuticals market is segmented into hospitals, imaging centers, academic and research centers, and others. In 2021, the hospitals segment is holding the largest share of the market. The market growth for this segment can be attributed to the rising prevalence of chronic diseases, increasing number of hospitals across the world, and rapidly growing number of surgical procedures. However, the market for the diagnostic centers segment is expected to grow at the fastest rate in the coming years.


Strategic Insights

Companies operating in the radiopharmaceuticals market are adopting the product innovations strategy to meet the evolving customer demands across the world, which also permits them to maintain their brand name in the global market.

Radiopharmaceuticals Market – by Type

  • Diagnostic Nuclear Medicine
    • SPECT Radiopharmaceuticals
    • PET Radiopharmaceuticals
  • Therapeutic Nuclear Medicine
    • Alpha Emitters
    • Beta Emitters
    • Brachytherapy Isotopes

Radiopharmaceuticals Market – by Product Type

  • Technetium-99m
  • Thallium-201
  • Gallium-67
  • Iodine-131
  • Copper-64
  • Other

Radiopharmaceuticals Market – by Application

  • Oncology
  • Cardiology
  • Neurology
  • Others

Radiopharmaceuticals Market – by End User

  • Hospitals
  • Imaging Centers
  • Academic and Research Centers
  • Others

Radiopharmaceuticals Market– by Geography

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • UK
    • Spain
    • Rest of Europe
  • Asia Pacific (APAC)
    • China
    • India
    • South Korea
    • Japan
    • Australia
    • Rest of APAC
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Rest of MEA
  • South and Central America (SCAM)
    • Brazil
    • Argentina
    • Rest of SCAM

Company Profiles

  • Cardinal Health
  • GE Healthcare
  • Curium
  • Lantheus Medical Imaging
  • Bayer AG
  • Bracco Imaging
  • Eczacýbaþý-Monrol Nuclear Products
  • Nordion
  • Advanced Accelerator Applications
  • NTP Radioisotopes

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Global Radiopharmaceuticals Market – By Type

1.3.2 Global Radiopharmaceuticals Market – By Product Type

1.3.3 Global Radiopharmaceuticals Market – By Application

1.3.4 Global Radiopharmaceuticals Market – By End User

1.3.5 Global Radiopharmaceuticals Market– By Geography

2. Global Radiopharmaceuticals Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Radiopharmaceuticals Market– Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 North America – PEST Analysis

4.2.2 Europe– PEST Analysis

4.2.3 Asia Pacific – PEST Analysis

4.2.4 Middle East and Africa – PEST Analysis

4.2.5 South and Central America (SCAM) – PEST Analysis

4.3 Experts Opinion

5. Radiopharmaceuticals Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Rising Prevalence of Chronic Diseases

5.1.2 Suitability of Alpha Radioimmunotherapy in Targeted Cancer Treatment

5.1.3 Advancements in Nuclear Imaging Techniques

5.2 Market Restraints

5.2.1 Short Shelf-Life of Radiopharmaceuticals

5.2.2 Availability of Substitutes

5.3 Market Opportunities

5.3.1 High Growth Potential in Developing Countries

5.4 Future Trends

5.4.1 Use of Nuclear Medicine for Personalized Treatment

5.5 Impact Analysis

6. Radiopharmaceuticals Market– Global Analysis

6.1 Global Radiopharmaceuticals Market Revenue Forecast and Analysis

6.2 Global Radiopharmaceuticals Market, By Geography - Forecast and Analysis

6.3 Market Positioning of Key Players

7. Radiopharmaceuticals Market Analysis – By Type

7.1 Overview

7.2 Radiopharmaceuticals Market Revenue Share, by Type (2021 and 2028)

7.3 Diagnostic Nuclear Medicine

7.3.1 Overview

7.3.2 Diagnostic Nuclear Medicine: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.3.3 (Single-Photon Emission Computed Tomography) Applications

7.3.3.1 Overview

7.3.3.2 SPECT (Single-Photon Emission Computed Tomography) Applications: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.3.4 PET (Positron Emission Tomography) Applications

7.3.4.1 Overview

7.3.4.2 PET (Positron Emission Tomography) Applications: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.4 Therapeutic Nuclear Medicine

7.4.1 Overview

7.4.2 Therapeutic Nuclear Medicine: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.4.3 Alpha Emitters

7.4.3.1 Overview

7.4.3.2 Alpha Emitters: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.4.4 Beta Emitters

7.4.4.1 Overview

7.4.4.2 Beta Emitters: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.4.5 Brachytherapy Isotopes

7.4.5.1 Overview

7.4.5.2 Brachytherapy Isotopes: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

8. Radiopharmaceuticals Market Analysis – By Product Type

8.1 Overview

8.2 Radiopharmaceuticals Market Revenue Share, by Product Type (2021 and 2028)

8.3 Iodine-131

8.3.1 Overview

8.3.2 Iodine-131: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

8.4 Gallium-67

8.4.1 Overview

8.4.2 Gallium-67: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

8.5 Thallium-201

8.5.1 Overview

8.5.2 Thallium-201: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

8.6 Technetium-99m

8.6.1 Overview

8.6.2 Technetium-99m: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

8.7 Copper-64

8.7.1 Overview

8.7.2 Copper-64: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

8.8 Other

8.8.1 Overview

8.8.2 Other: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

9. Radiopharmaceuticals Market Analysis – By Application

9.1 Overview

9.2 Radiopharmaceuticals Market Revenue Share, by Application (2021 and 2028)

9.3 Oncology

9.3.1 Overview

9.3.2 Oncology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

9.4 Cardiology

9.4.1 Overview

9.4.2 Cardiology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

9.5 Neurology

9.5.1 Overview

9.5.2 Neurology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

9.6 Others

9.6.1 Overview

9.6.2 Others: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

10. Radiopharmaceuticals Market Analysis – By End User

10.1 Overview

10.2 Radiopharmaceuticals Market Share, by End User, 2021 and 2028, (%)

10.3 Hospitals

10.3.1 Overview

10.3.2 Hospitals: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

10.4 Imaging Centres

10.4.1 Overview

10.4.2 Imaging Centres: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

10.5 Academic and Research Centers

10.5.1 Overview

10.5.2 Academic and Research Centers: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

10.6 Others

10.6.1 Overview

10.6.2 Others: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

11. Global Radiopharmaceuticals Market – Geographic Analysis

11.1 North America: Radiopharmaceuticals Market

11.1.1 Overview

11.1.2 North America: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

11.1.3 North America: Radiopharmaceuticals Market, by Type, 2019–2028 (USD Million)

11.1.3.1 North America: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)

11.1.3.2 North America: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)

11.1.4 North America: Radiopharmaceuticals Market, by Application, 2019–2028 (USD Million)

11.1.5 North America: Radiopharmaceuticals Market, by End User, 2019–2028 (USD Million)

11.1.6 North America: Radiopharmaceuticals Market, by Country, 2021 & 2028 (%)

11.1.6.1 US: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (USD Million)

11.1.6.1.1 US: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

11.1.6.1.2 US: Radiopharmaceuticals Market, by Type, 2019–2028 (USD Million)

11.1.6.1.2.1 US: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)

11.1.6.1.2.2 US: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)

11.1.6.1.3 US: Radiopharmaceuticals Market, by Application, 2019–2028 (USD Million)

11.1.6.1.4 US: Radiopharmaceuticals Market, by End User, 2019–2028 (USD Million)

11.1.6.2 Canada: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

11.1.6.2.1 Canada: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

11.1.6.2.2 Canada: Radiopharmaceuticals Market, by Type, 2019–2028 (USD Million)

11.1.6.2.2.1 North America: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)

11.1.6.2.2.2 North America: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)

11.1.6.2.3 Canada: Radiopharmaceuticals Market, by Application, 2019–2028 (USD Million)

11.1.6.2.4 Canada: Radiopharmaceuticals Market, by End User, 2019–2028 (USD Million)

11.1.6.3 Mexico: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

11.1.6.3.1 Mexico: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

11.1.6.3.2 Mexico: Radiopharmaceuticals Market, by Type – 2019–2028 (USD Million)

11.1.6.3.2.1 Mexico: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)

11.1.6.3.2.2 Mexico: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)

11.1.6.3.3 Mexico: Radiopharmaceuticals Market, by Application, 2019–2028 (USD Million)

11.1.6.3.4 Mexico: Radiopharmaceuticals Market, by End User, 2019–2028 (USD Million)

11.2 Europe: Radiopharmaceuticals Market

11.2.1 Overview

11.2.2 Europe: Radiopharmaceuticals Market - Revenue and Forecast to 2028 (USD Million)

11.2.3 Europe: Radiopharmaceuticals Market, By Type, 2019–2028 (USD Million)

11.2.3.1 Europe: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)

11.2.3.2 Europe: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)

11.2.4 Europe: Radiopharmaceuticals Market, by Application, 2019–2028 (USD Million)

11.2.5 Europe: Radiopharmaceuticals Market, by End User, 2019–2028 (USD Million)

11.2.6 Europe: Radiopharmaceuticals Market, by Country, 2021 & 2028 (%)

11.2.6.1 Germany: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

11.2.6.1.1 Germany: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

11.2.6.1.2 Germany: Radiopharmaceuticals Market, By Type, 2019–2028 (USD Million)

11.2.6.1.2.1 Germany: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)

11.2.6.1.2.2 Germany: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)

11.2.6.1.3 Germany: Radiopharmaceuticals Market, by Application, 2019–2028 (USD Million)

11.2.6.1.4 Germany: Radiopharmaceuticals Market, by End User, 2019–2028 (USD Million)

11.2.6.2 France: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

11.2.6.2.1 France: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

11.2.6.2.2 France: Radiopharmaceuticals Market, By Type, 2019–2028 (USD Million)

11.2.6.2.2.1 France: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)

11.2.6.2.2.2 France: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)

11.2.6.2.3 France: Radiopharmaceuticals Market, by Application, 2019–2028 (USD Million)

11.2.6.2.4 France: Radiopharmaceuticals Market, by End User, 2019–2028 (USD Million)

11.2.6.3 UK: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

11.2.6.3.1 UK: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

11.2.6.3.2 UK: Radiopharmaceuticals Market, By Type, 2019–2028 (USD Million)

11.2.6.3.2.1 UK: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)

11.2.6.3.2.2 UK: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)

11.2.6.3.3 UK: Radiopharmaceuticals Market, by Application, 2019–2028 (USD Million)

11.2.6.3.4 UK: Radiopharmaceuticals Market, by End User, 2019–2028 (USD Million)

11.2.6.4 Italy: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

11.2.6.4.1 Italy: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

11.2.6.4.2 Italy: Radiopharmaceuticals Market, By Type, 2019–2028 (USD Million)

11.2.6.4.2.1 Italy: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)

11.2.6.4.2.2 Italy: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)

11.2.6.4.3 Italy: Radiopharmaceuticals Market, by Application, 2019–2028 (USD Million)

11.2.6.4.4 Italy: Radiopharmaceuticals Market, by End User, 2019–2028 (USD Million)

11.2.6.5 Spain: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

11.2.6.5.1 Spain: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

11.2.6.5.2 Spain: Radiopharmaceuticals Market, By Type, 2019–2028 (USD Million)

11.2.6.5.2.1 Spain: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)

11.2.6.5.2.2 Spain: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)

11.2.6.5.3 Spain: Radiopharmaceuticals Market, by Application, 2019–2028 (USD Million)

11.2.6.5.4 Spain: Radiopharmaceuticals Market, by End User, 2019–2028 (USD Million)

11.2.6.6 Rest of Europe: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

11.2.6.6.1 Rest of Europe: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

11.2.6.6.2 Rest of Europe: Radiopharmaceuticals Market, By Type, 2019–2028 (USD Million)

11.2.6.6.2.1 Rest of Europe: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)

11.2.6.6.2.2 Rest of Europe: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)

11.2.6.6.3 Rest of Europe: Radiopharmaceuticals Market, by Application, 2019–2028 (USD Million)

11.2.6.6.4 Rest of Europe: Radiopharmaceuticals Market, by End User, 2019–2028 (USD Million)

11.3 Asia Pacific: Radiopharmaceuticals Market

11.3.1 Overview

11.3.2 Asia Pacific: Radiopharmaceuticals Market - Revenue and Forecast to 2028 (USD Million)

11.3.3 Asia Pacific: Radiopharmaceuticals Market, By Type, 2019–2028 (USD Million)

11.3.3.1 Asia Pacific: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)

11.3.3.2 Asia Pacific: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)

11.3.4 Asia Pacific: Radiopharmaceuticals Market, by Application, 2019–2028 (USD Million)

11.3.5 Asia Pacific: Radiopharmaceuticals Market, by End User, 2019–2028 (USD Million)

11.3.6 Asia Pacific: Radiopharmaceuticals Market, by Country, 2021 & 2028 (%)

11.3.6.1 China: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

11.3.6.1.1 China: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

11.3.6.1.2 China: Radiopharmaceuticals Market, By Type, 2019–2028 (USD Million)

11.3.6.1.2.1 China: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)

11.3.6.1.2.2 China: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)

11.3.6.1.3 China: Radiopharmaceuticals Market, by Application, 2019–2028 (USD Million)

11.3.6.1.4 China: Radiopharmaceuticals Market, by End User, 2019–2028 (USD Million)

11.3.6.2 Japan: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

11.3.6.2.1 Japan: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

11.3.6.2.2 Japan: Radiopharmaceuticals Market, By Type, 2019–2028 (USD Million)

11.3.6.2.2.1 Japan: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)

11.3.6.2.2.2 Japan: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)

11.3.6.2.3 Japan: Radiopharmaceuticals Market, by Application, 2019–2028 (USD Million)

11.3.6.2.4 Japan: Radiopharmaceuticals Market, by End User, 2019–2028 (USD Million)

11.3.6.3 India: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

11.3.6.3.1 India: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

11.3.6.3.2 India: Radiopharmaceuticals Market, By Type, 2019–2028 (USD Million)

11.3.6.3.2.1 India: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)

11.3.6.3.2.2 India: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)

11.3.6.3.3 India: Radiopharmaceuticals Market, by Application, 2019–2028 (USD Million)

11.3.6.3.4 India: Radiopharmaceuticals Market, by End User, 2019–2028 (USD Million)

11.3.6.4 Australia: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

11.3.6.4.1 Australia: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

11.3.6.4.2 Australia: Radiopharmaceuticals Market, By Type, 2019–2028 (USD Million)

11.3.6.4.2.1 Australia: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)

11.3.6.4.2.2 Australia: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)

11.3.6.4.3 Australia: Radiopharmaceuticals Market, by Application, 2019–2028 (USD Million)

11.3.6.4.4 Australia: Radiopharmaceuticals Market, by End User, 2019–2028 (USD Million)

11.3.6.5 South Korea: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

11.3.6.5.1 South Korea: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

11.3.6.5.2 South Korea: Radiopharmaceuticals Market, By Type, 2019–2028 (USD Million)

11.3.6.5.2.1 South Korea: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)

11.3.6.5.2.2 South Korea: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)

11.3.6.5.3 South Korea: Radiopharmaceuticals Market, by Application, 2019–2028 (USD Million)

11.3.6.5.4 South Korea: Radiopharmaceuticals Market, by End User, 2019–2028 (USD Million)

11.3.6.6 Rest of Asia Pacific: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

11.3.6.6.1 Rest of Asia Pacific: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

11.3.6.6.2 Rest of Asia Pacific: Radiopharmaceuticals Market, By Type, 2019–2028 (USD Million)

11.3.6.6.2.1 Rest of Asia Pacific: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)

11.3.6.6.2.2 Rest of Asia Pacific: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)

11.3.6.6.3 Rest of Asia Pacific: Radiopharmaceuticals Market, by Application, 2019–2028 (USD Million)

11.3.6.6.4 Rest of Asia Pacific: Radiopharmaceuticals Market, by End User, 2019–2028 (USD Million)

11.4 Middle East and Africa: Radiopharmaceuticals Market

11.4.1 Overview

11.4.2 Middle East & Africa: Radiopharmaceuticals Market- Revenue and Forecast to 2028 (US$ Million)

11.4.3 Middle East and Africa Radiopharmaceuticals Market, by Type– Revenue and Forecast to 2028 (USD Million)

11.4.3.1 Middle East and Africa: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)

11.4.3.2 Middle East and Africa: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)

11.4.4 Middle East and Africa Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)

11.4.5 Middle East and Africa Radiopharmaceuticals Market, by End User– Revenue and Forecast to 2028 (USD Million)

11.4.6 Middle East and Africa: Radiopharmaceuticals Market, by Country, 2021 & 2028 (%)

11.4.6.1 Saudi Arabia: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (US$ Million)

11.4.6.1.1 Saudi Arabia: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (US$ Million)

11.4.6.1.2 Saudi Arabia Radiopharmaceuticals Market, by Type– Revenue and Forecast to 2028 (USD Million)

11.4.6.1.2.1 Saudi Arabia: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)

11.4.6.1.2.2 Saudi Arabia: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)

11.4.6.1.3 Saudi Arabia Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)

11.4.6.1.4 Saudi Arabia Radiopharmaceuticals Market, by End User– Revenue and Forecast to 2028 (USD Million)

11.4.6.2 UAE: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (US$ Million)

11.4.6.2.1 UAE: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (US$ Million)

11.4.6.2.2 UAE Radiopharmaceuticals Market, by Type– Revenue and Forecast to 2028 (USD Million)

11.4.6.2.2.1 UAE: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)

11.4.6.2.2.2 UAE a: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)

11.4.6.2.3 UAE Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)

11.4.6.2.4 UAE Radiopharmaceuticals Market, by End User – Revenue and Forecast to 2028 (USD Million)

11.4.6.3 South Africa: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (US$ Million)

11.4.6.3.1 South Africa: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (US$ Million)

11.4.6.3.2 South Africa Radiopharmaceuticals Market, by Type– Revenue and Forecast to 2028 (USD Million)

11.4.6.3.2.1 South Africa: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)

11.4.6.3.2.2 South Africa: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)

11.4.6.3.3 South Africa Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)

11.4.6.3.4 South Africa Radiopharmaceuticals Market, by End User – Revenue and Forecast to 2028 (USD Million)

11.4.6.4 Rest of Middle East and Africa: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (US$ Million)

11.4.6.4.1 Rest of Middle East and Africa: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (US$ Million)

11.4.6.4.2 Rest of Middle East and Africa Radiopharmaceuticals Market, by Type– Revenue and Forecast to 2028 (USD Million)

11.4.6.4.2.1 Rest of Middle East and Africa: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)

11.4.6.4.2.2 Rest of Middle East and Africa: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)

11.4.6.4.3 Rest of Middle East and Africa Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)

11.4.6.4.4 Rest of Middle East and Africa Radiopharmaceuticals Market, by End User– Revenue and Forecast to 2028 (USD Million)

11.5 South and Central America: Radiopharmaceuticals Market

11.5.1 Overview

11.5.2 South and Central America: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (USD Million)

11.5.3 South and Central America Radiopharmaceuticals Market, by Type – Revenue and Forecast to 2028 (USD Million)

11.5.3.1 South and Central America: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)

11.5.3.2 South and Central America: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)

11.5.4 South and Central America Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)

11.5.5 South and Central America Radiopharmaceuticals Market, by End User– Revenue and Forecast to 2028 (USD Million)

11.5.6 South and Central America: Radiopharmaceuticals Market, by Country, 2021 & 2028 (%)

11.5.6.1 Brazil: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (USD Million)

11.5.6.1.1 Brazil: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (USD Million)

11.5.6.1.2 Brazil Radiopharmaceuticals Market, by Type– Revenue and Forecast to 2028 (USD Million)

11.5.6.1.2.1 Brazil: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)

11.5.6.1.2.2 Brazil: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)

11.5.6.1.3 Brazil Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)

11.5.6.1.4 Brazil Radiopharmaceuticals Market, by End User– Revenue and Forecast to 2028 (USD Million)

11.5.6.2 Argentina: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (USD Million)

11.5.6.2.1 Argentina: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (USD Million)

11.5.6.2.2 Argentina Radiopharmaceuticals Market, by Type– Revenue and Forecast to 2028 (USD Million)

11.5.6.2.2.1 Argentina: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)

11.5.6.2.2.2 Argentina: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)

11.5.6.2.3 Argentina Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)

11.5.6.2.4 Argentina Radiopharmaceuticals Market, by End User– Revenue and Forecast to 2028 (USD Million)

11.5.6.3 Rest of South and Central America: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (USD Million)

11.5.6.3.1 Rest of South and Central America: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (USD Million)

11.5.6.3.2 Rest of South and Central America Radiopharmaceuticals Market, by Type– Revenue and Forecast to 2028 (USD Million)

11.5.6.3.2.1 Rest of South and Central America: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)

11.5.6.3.2.2 Rest of South and Central America: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)

11.5.6.3.3 Rest of South and Central America Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)

11.5.6.3.4 Rest of South and Central America Radiopharmaceuticals Market, by End User– Revenue and Forecast to 2028 (USD Million)

12. Impact Of COVID-19 Pandemic on Radiopharmaceuticals Market

12.1 North America: Impact Assessment of COVID-19 Pandemic

12.2 Europe: Impact Assessment of COVID-19 Pandemic

12.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic

12.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic

12.5 South & Central America: Impact Assessment of COVID-19 Pandemic

13. Radiopharmaceuticals Market–Industry Landscape

13.1 Overview

13.2 Growth Strategies Done by the Companies in the Market, (%)

13.3 Inorganic Growth Strategies

13.3.1 Overview

13.4 Organic Growth Strategies

13.4.1 Overview

14. Company Profiles

14.1 Cardinal Health Inc

14.1.1 Key Facts

14.1.2 Business Description

14.1.3 Products and Services

14.1.4 Financial Overview

14.1.5 SWOT Analysis

14.1.6 Key Developments

14.2 Curium

14.2.1 Key Facts

14.2.2 Business Description

14.2.3 Products and Services

14.2.4 Financial Overview

14.2.5 SWOT Analysis

14.2.6 Key Developments

14.3 GENERAL ELECTRIC

14.3.1 Key Facts

14.3.2 Business Description

14.3.3 Products and Services

14.3.4 Financial Overview

14.3.5 SWOT Analysis

14.3.6 Key Developments

14.4 Lantheus Medical Imaging, Inc.

14.4.1 Key Facts

14.4.2 Business Description

14.4.3 Products and Services

14.4.4 Financial Overview

14.4.5 SWOT Analysis

14.4.6 Key Developments

14.5 Bayer AG

14.5.1 Key Facts

14.5.2 Business Description

14.5.3 Products and Services

14.5.4 Financial Overview

14.5.5 SWOT Analysis

14.5.6 Key Developments

14.6 Bracco Imaging S.p.A

14.6.1 Key Facts

14.6.2 Business Description

14.6.3 Products and Services

14.6.4 Financial Overview

14.6.5 SWOT Analysis

14.6.6 Key Developments

14.7 ECZACIBA?I MONROL NUCLEAR PRODUCTS CO.

14.7.1 Key Facts

14.7.2 Business Description

14.7.3 Products and Services

14.7.4 Financial Overview

14.7.5 SWOT Analysis

14.7.6 Key Developments

14.8 Nordion

14.8.1 Key Facts

14.8.2 Business Description

14.8.3 Products and Services

14.8.4 Financial Overview

14.8.5 SWOT Analysis

14.8.6 Key Developments

14.9 NTP RADIOISOTOPES

14.9.1 Key Facts

14.9.2 Business Description

14.9.3 Products and Services

14.9.4 Financial Overview

14.9.5 SWOT Analysis

14.9.6 Key Developments

14.10 Advanced Accelerator Applications

14.10.1 Key Facts

14.10.2 Business Description

14.10.3 Products and Services

14.10.4 Financial Overview

14.10.5 SWOT Analysis

14.10.6 Key Developments

15. Appendix

15.1 About The Insight Partners

15.2 Glossary of Terms

LIST OF TABLES

Table 1. Principal Radionuclides Used in Diagnostic Radiopharmaceuticals

Table 2. North America Radiopharmaceuticals Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 3. North America Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 4. North America Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 5. North America Radiopharmaceuticals Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 6. North America Radiopharmaceuticals Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 7. US Radiopharmaceuticals Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 8. US Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 9. US Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 10. US Radiopharmaceuticals Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 11. US Radiopharmaceuticals Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 12. Canada Radiopharmaceuticals Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 13. North America Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 14. North America Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 15. Canada Radiopharmaceuticals Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 16. Canada Radiopharmaceuticals Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 17. Mexico Radiopharmaceuticals Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 18. Mexico Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 19. Mexico Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 20. Mexico Radiopharmaceuticals Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 21. Mexico Radiopharmaceuticals Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 22. Europe: Radiopharmaceuticals Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 23. Europe Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 24. Europe Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 25. Europe Radiopharmaceuticals Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 26. Europe Radiopharmaceuticals Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 27. Germany: Radiopharmaceuticals Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 28. Germany Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 29. Germany Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 30. Germany: Radiopharmaceuticals Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 31. Germany: Radiopharmaceuticals Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 32. France: Radiopharmaceuticals Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 33. France Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 34. France Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 35. France: Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)

Table 36. France: Radiopharmaceuticals Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 37. UK: Radiopharmaceuticals Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 38. UK Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 39. UK Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 40. UK: Radiopharmaceuticals Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 41. UK: Radiopharmaceuticals Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 42. Italy: Radiopharmaceuticals Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 43. Italy Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 44. Italy Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 45. Italy: Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)

Table 46. Italy: Radiopharmaceuticals Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 47. Spain: Radiopharmaceuticals Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 48. Spain Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 49. Spain Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 50. Spain: Radiopharmaceuticals Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 51. Spain: Radiopharmaceuticals Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 52. Rest of Europe: Radiopharmaceuticals Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 53. Rest of Europe Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 54. Rest of Europe Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 55. Rest of Europe: Radiopharmaceuticals Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 56. Rest of Europe: Radiopharmaceuticals Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 57. Asia Pacific: Radiopharmaceuticals Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 58. Asia Pacific Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 59. Asia Pacific Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 60. Asia Pacific Radiopharmaceuticals Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 61. Asia Pacific Radiopharmaceuticals Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 62. China: Radiopharmaceuticals Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 63. China Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 64. China Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 65. China: Radiopharmaceuticals Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 66. China: Radiopharmaceuticals Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 67. Japan: Radiopharmaceuticals Market, By Type– Revenue and Forecast to 2028 (USD Million)

Table 68. Japan Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 69. Japan Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 70. Japan: Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)

Table 71. Japan: Radiopharmaceuticals Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 72. India: Radiopharmaceuticals Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 73. India Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 74. India Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 75. India: Radiopharmaceuticals Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 76. India: Radiopharmaceuticals Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 77. Australia: Radiopharmaceuticals Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 78. Australia Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 79. Australia Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 80. Australia: Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)

Table 81. Australia: Radiopharmaceuticals Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 82. South Korea: Radiopharmaceuticals Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 83. South Korea Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 84. South Korea Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 85. South Korea: Radiopharmaceuticals Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 86. South Korea: Radiopharmaceuticals Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 87. Rest of Asia Pacific: Radiopharmaceuticals Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 88. Rest of Asia Pacific Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 89. Rest of Asia Pacific Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 90. Rest of Asia Pacific: Radiopharmaceuticals Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 91. Rest of Asia Pacific: Radiopharmaceuticals Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 92. Middle East and Africa Radiopharmaceuticals Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 93. Middle East and Africa Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 94. Middle East and Africa Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 95. Middle East and Africa Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)

Table 96. Middle East and Africa Radiopharmaceuticals Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 97. Saudi Arabia Radiopharmaceuticals Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 98. Saudi Arabia Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 99. Saudi Arabia Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 100. Saudi Arabia Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)

Table 101. Saudi Arabia Radiopharmaceuticals Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 102. UAE Radiopharmaceuticals Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 103. UAE Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 104. UAE Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 105. UAE Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)

Table 106. UAE Radiopharmaceuticals Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 107. South Africa Radiopharmaceuticals Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 108. South Africa Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 109. South Africa Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 110. South Africa Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)

Table 111. South Africa Radiopharmaceuticals Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 112. Rest of Middle East and Africa Radiopharmaceuticals Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 113. Rest of Middle East and Africa Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 114. Rest of Middle East and Africa Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 115. Rest of Middle East and Africa Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)

Table 116. Rest of Middle East and Africa Radiopharmaceuticals Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 117. South and Central America Radiopharmaceuticals Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 118. South and Central America Africa Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 119. South and Central America Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 120. South and Central America Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)

Table 121. South and Central America Radiopharmaceuticals Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 122. Brazil Radiopharmaceuticals Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 123. Brazil Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 124. Brazil Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 125. Brazil Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)

Table 126. Brazil Radiopharmaceuticals Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 127. Argentina Radiopharmaceuticals Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 128. Argentina Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 129. Argentina Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 130. Argentina Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)

Table 131. Argentina Radiopharmaceuticals Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 132. Rest of South and Central America Radiopharmaceuticals Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 133. Rest of South and Central America Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 134. Rest of South and Central America Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 135. Rest of South and Central America Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)

Table 136. Rest of South and Central America Radiopharmaceuticals Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 137. Recent Inorganic Growth Strategies in the Radiopharmaceuticals Market

Table 138. Recent Organic Growth Strategies in the Radiopharmaceuticals Market

Table 139. Glossary of Terms, Radiopharmaceuticals Market

LIST OF FIGURES

Figure 1. Radiopharmaceuticals Market Segmentation

Figure 2. Radiopharmaceuticals Market Segmentation, By Region

Figure 3. Global Radiopharmaceuticals Market Overview

Figure 4. Diagnostic Nuclear Medicine Segment Held the Largest Share of the Type Segment in Radiopharmaceuticals Market

Figure 5. Asia Pacific to Show Significant Growth During Forecast Period

Figure 6. Radiopharmaceuticals Market, by Geography (US$ Million)

Figure 7. Global Radiopharmaceuticals Market– Leading Country Markets (US$ Million)

Figure 8. Global Radiopharmaceuticals Market, Industry Landscape

Figure 9. North America PEST Analysis

Figure 10. Europe and PEST Analysis

Figure 11. Asia Pacific PEST Analysis

Figure 12. Middle East and Africa PEST Analysis

Figure 13. South and Central America (SCAM) PEST Analysis

Figure 14. Radiopharmaceuticals Market Impact Analysis of Drivers and Restraints

Figure 15. Global Radiopharmaceuticals Market– Revenue Forecast and Analysis – 2020- 2028

Figure 16. Global Radiopharmaceuticals Market – By Geography Forecast and Analysis – 2021- 2028

Figure 17. Market Positioning of Key Players in Global Radiopharmaceuticals Market

Figure 18. Radiopharmaceuticals Market Revenue Share, by Type (2021 and 2028)

Figure 19. Diagnostic Nuclear Medicine: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20. SPECT (Single-Photon Emission Computed Tomography) Applications: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21. PET (Positron Emission Tomography) Applications: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22. Therapeutic Nuclear Medicine: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23. Alpha Emitters: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24. Beta Emitters: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25. Brachytherapy Isotopes: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26. Radiopharmaceuticals Market Revenue Share, by Product Type (2021 and 2028)

Figure 27. Iodine-131: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 28. Gallium-67: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 29. Thallium-201: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 30. Technetium-99m: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 31. Copper-64: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 32. Other: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 33. Radiopharmaceuticals Market Revenue Share, by Application (2021 and 2028)

Figure 34. Oncology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 35. Cardiology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 36. Neurology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 37. Others: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 38. Radiopharmaceuticals Market Share, by End User, 2021 and 2028 (%)

Figure 39. Hospitals: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 40. Imaging Centres: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 41. Academic and Research Centers: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 42. Others: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 43. North America: Radiopharmaceuticals Market, by Key Country – Revenue (2021) (USD Million)

Figure 44. North America Radiopharmaceuticals Market Revenue and Forecast to 2028 (USD Million)

Figure 45. North America: Radiopharmaceuticals Market, by Country, 2021 & 2028 (%)

Figure 46. US: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

Figure 47. Canada: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

Figure 48. Mexico: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

Figure 49. Europe: Radiopharmaceuticals Market, by Key Country – Revenue (2021) (USD Million)

Figure 50. Europe Radiopharmaceuticals Market Revenue and Forecast to 2028 (USD Million)

Figure 51. Europe: Radiopharmaceuticals Market, by Country, 2021 & 2028 (%)

Figure 52. Germany: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

Figure 53. France: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

Figure 54. UK: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

Figure 55. Italy: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

Figure 56. Spain: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

Figure 57. Rest of Europe: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

Figure 58. Asia Pacific: Radiopharmaceuticals Market, by Key Country – Revenue (2021) (USD Million)

Figure 59. Asia Pacific Radiopharmaceuticals Market Revenue and Forecast to 2028 (USD Million)

Figure 60. Asia Pacific: Radiopharmaceuticals Market, by Country, 2021 & 2028 (%)

Figure 61. China: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

Figure 62. Japan: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

Figure 63. India: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

Figure 64. Australia: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

Figure 65. South Korea: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

Figure 66. Rest of Asia Pacific: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

Figure 67. Middle East and Africa: Radiopharmaceuticals Market, by Key Country – Revenue (2021) (USD Million)

Figure 68. Middle East & Africa Radiopharmaceuticals Market Revenue and Forecast to 2028 (US$ Million)

Figure 69. Middle East and Africa: Radiopharmaceuticals Market, by Country, 2021 & 2028 (%)

Figure 70. Saudi Arabia: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (US$ Million)

Figure 71. UAE: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (US$ Million)

Figure 72. South Africa: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (US$ Million)

Figure 73. Rest of Middle East and Africa: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (US$ Million)

Figure 74. South and Central America: Radiopharmaceuticals Market, by Key Country – Revenue (2021) (USD Million)

Figure 75. South and Central America Radiopharmaceuticals Market Revenue and Forecast to 2028 (USD Million)

Figure 76. South and Central America: Radiopharmaceuticals Market, by Country, 2021 & 2028 (%)

Figure 77. Brazil: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (USD Million)

Figure 78. Argentina: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (USD Million)

Figure 79. Rest of South and Central America: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (USD Million)

Figure 80. Impact of COVID-19 Pandemic in North American Country Markets

Figure 81. Impact of COVID-19 Pandemic in European Country Markets

Figure 82. Impact of COVID-19 Pandemic in Asia Pacific Country Markets

Figure 83. Impact of COVID-19 Pandemic in Middle East and Africa Country Markets

Figure 84. Impact of COVID-19 Pandemic in South & Central America Market

Figure 85. Growth Strategies Done by the Companies in the Market, (%)

The List of Companies - Radiopharmaceuticals Market

  1. Cardinal Health
  2. GE Healthcare
  3. Curium
  4. Lantheus Medical Imaging
  5. Bayer AG
  6. Bracco Imaging
  7. Eczacýbaþý-Monrol Nuclear Products
  8. Nordion
  9. Advanced Accelerator Applications
  10. NTP Radioisotopes
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the radiopharmaceuticals market. 
  • Highlights key business priorities in order to assist companies to realign their business strategies. 
  • The key findings and recommendations highlight crucial progressive industry trends in the global radiopharmaceuticals market, thereby allowing players across the value chain to develop effective long-term strategies. 
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets. 
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it. 
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
TIPRE00003751
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Frequently Asked Questions

Radiopharmaceuticals are radioisotopes that are bound to biological molecules that target specific tissues, organs, or cells within the human body. Radioisotopes emitting gamma rays are useful for diagnostic imaging where the radiation escapes the body. These rays are detected by a specific device, which is usually single-photon emission computed tomography (SPECT)/ positron emission tomography (PET) cameras.

The factors that are driving growth of the market are rising prevalence of chronic diseases, suitability of alpha radioimmunotherapy in targeted cancer treatment, and advancements in nuclear imaging techniques.

Various companies have made organic growth strategies in the Radiopharmaceuticals Market. Some of the activities undertaken by the company, which have promoted its growth are, launches, enhancements and expansion & relocation activities. Companies such as Lantheus Medical Imaging, Inc., Bracco Imaging S.p.A, Advanced Accelerator Applications amongst others are some of the companies that have been implementing various organic strategies that have helped the growth of the company.

North America dominates the global radiopharmaceuticals market due to factors such as technological advancement, increasing product launches, well-developed healthcare facility centres equipped with modern-age equipment and instruments.

The diagnostic nuclear medicine segment is growing at the highest CAGR owing to availability of diagnostic devices and ease offered by these devices for diagnosis of various disorders. Also, nuclear medicine provides better diagnostic information about the functioning of a specific organ, as it uses radiation.

Asia Pacific is expected to be the fastest growing region in the radiopharmaceuticals market. The growth of the market in this region is primarily due to prevalence of stroke and other neurological disorders along with the presence of supportive government initiatives and research in the field of radiopharmaceuticals.

Pricing
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.